Stereotaxis (STXS) Achieves CE Mark in Europe for GenesisX
https://www.zacks.com/stock/news/2322488/stereotaxis-stxs-achieves-ce-mark-in-europe-for-genesisx?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2322488
Aug 15, 2024 - Stereotaxis (STXS) gets a CE mark in Europe for its GenesisX robotic system. Following this, the company also submits a 501(k) application for FDA clearance.
0
Chemours (CC) Opens Cutting-Edge Facility for EV Batteries
https://www.zacks.com/stock/news/2322429/chemours-cc-opens-cutting-edge-facility-for-ev-batteries?cid=CS-ZC-FT-analyst_blog|company_news_corporate_actions-2322429
Aug 15, 2024 - Chemours (CC) opens the Chemours Battery Innovation Center to advance sustainable battery technology for electric vehicles.
0
Celanese (CE) Reports Q2 Earnings: What Key Metrics Have to Say
https://www.zacks.com/stock/news/2314736/celanese-ce-reports-q2-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2314736
Aug 01, 2024 - Although the revenue and EPS for Celanese (CE) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
0
Inspire Medical's (INSP) Inspire Therapy Gets CE Mark Approval
https://www.zacks.com/stock/news/2306208/inspire-medical-s-insp-inspire-therapy-gets-ce-mark-approval?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2306208
Jul 22, 2024 - Inspire Medical's (INSP) receipt of the latest CE mark certification will likely enable it to continue to deliver Inspire products globally.
0
Roche Holding's (RHHBY) Accu-Chek SmartGuide Receives CE Mark
https://www.zacks.com/stock/news/2301047/roche-holding-s-rhhby-accu-chek-smartguide-receives-ce-mark?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2301047
Jul 12, 2024 - Roche Holding (RHHBY) announces the receipt of CE Mark for its Accu-Chek SmartGuide CGM solution which is intended toward providing better diabetes management.
0
Here's Why You Should Hold Onto Celanese (CE) Stock for Now
https://www.zacks.com/stock/news/2298431/here-s-why-you-should-hold-onto-celanese-ce-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2298431
Jul 09, 2024 - Celanese (CE) benefits from its productivity measures, investments in organic projects, expansion actions and strategic acquisitions amid headwinds from demand softness and pricing pressures.
0
Boston Scientific (BSX) DBS Programming Software Gets CE Mark
https://www.zacks.com/stock/news/2293742/boston-scientific-bsx-dbs-programming-software-gets-ce-mark?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2293742
Jun 26, 2024 - Boston Scientific (BSX) secures CE Mark for the DBS image-guided programming software, Vercise Neural Navigator 5.
0
Celanese (CE) Gains on Cost Actions Amid Demand & Pricing Woes
https://www.zacks.com/stock/news/2289072/celanese-ce-gains-on-cost-actions-amid-demand-pricing-woes?cid=CS-ZC-FT-analyst_blog|zer_report_update-2289072
Jun 17, 2024 - While Celanese (CE) faces headwinds from soft demand and pricing, it benefits from productivity measures, investments in organic projects and strategic acquisitions.
0
Abbott's (ABT) AVEIR DR Leadless Pacemaker System Gains CE Mark
https://www.zacks.com/stock/news/2287251/abbott-s-abt-aveir-dr-leadless-pacemaker-system-gains-ce-mark?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2287251
Jun 12, 2024 - Abbott (ABT) receives a CE mark for AVEIR DR, the world's first dual chamber leadless pacemaker system.
0
Why Celanese (CE) is a Top Value Stock for the Long-Term
https://www.zacks.com/stock/news/2281327/why-celanese-ce-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2281327
May 30, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
0